Form 4: Anixa Biosciences CEO Amit Kumar Acquires 30,000 Shares
SEC Form 4 Filing
Anixa Biosciences CEO Amit Kumar reports purchasing 30,000 shares of the company's common stock at $3.22 per share on March 15, 2024.
Summary
- On March 15, 2024, Amit Kumar, the CEO of Anixa Biosciences Inc., acquired 30,000 shares of common stock.
- The purchase price was $3.22 per share.
- Following the transaction, Kumar directly owns 491,925 shares of Anixa Biosciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but the impact is limited without more context.
Positives
- The CEO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often watched by investors as an indicator of management's sentiment about the company's prospects. It can be a positive signal, but should be considered alongside other factors.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of the stock purchase transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.